271 related articles for article (PubMed ID: 27342567)
1. Cardioprotection by H2S Donors: Nitric Oxide-Dependent and ‑Independent Mechanisms.
Chatzianastasiou A; Bibli SI; Andreadou I; Efentakis P; Kaludercic N; Wood ME; Whiteman M; Di Lisa F; Daiber A; Manolopoulos VG; Szabó C; Papapetropoulos A
J Pharmacol Exp Ther; 2016 Sep; 358(3):431-40. PubMed ID: 27342567
[TBL] [Abstract][Full Text] [Related]
2. Hydrogen Sulfide Preserves Endothelial Nitric Oxide Synthase Function by Inhibiting Proline-Rich Kinase 2: Implications for Cardiomyocyte Survival and Cardioprotection.
Bibli SI; Szabo C; Chatzianastasiou A; Luck B; Zukunft S; Fleming I; Papapetropoulos A
Mol Pharmacol; 2017 Dec; 92(6):718-730. PubMed ID: 29030392
[TBL] [Abstract][Full Text] [Related]
3. Using mechanism-based combinations of H
Ravani S; Chatzianastasiou A; Papapetropoulos A
Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; 397(3):1853-1864. PubMed ID: 37773523
[TBL] [Abstract][Full Text] [Related]
4. A novel class of cardioprotective small-molecule PTP inhibitors.
Antonucci S; Di Sante M; Sileikyte J; Deveraux J; Bauer T; Bround MJ; Menabò R; Paillard M; Alanova P; Carraro M; Ovize M; Molkentin JD; Cohen M; Forte MA; Bernardi P; Di Lisa F; Murphy E
Pharmacol Res; 2020 Jan; 151():104548. PubMed ID: 31759087
[TBL] [Abstract][Full Text] [Related]
5. The novel H
Testai L; Marino A; Piano I; Brancaleone V; Tomita K; Di Cesare Mannelli L; Martelli A; Citi V; Breschi MC; Levi R; Gargini C; Bucci M; Cirino G; Ghelardini C; Calderone V
Pharmacol Res; 2016 Nov; 113(Pt A):290-299. PubMed ID: 27616550
[TBL] [Abstract][Full Text] [Related]
6. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Liu YN; Zhou ZM; Chen P
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological postconditioning against myocardial infarction with a slow-releasing hydrogen sulfide donor, GYY4137.
Karwi QG; Whiteman M; Wood ME; Torregrossa R; Baxter GF
Pharmacol Res; 2016 Sep; 111():442-451. PubMed ID: 27378570
[TBL] [Abstract][Full Text] [Related]
8. Zofenopril Protects Against Myocardial Ischemia-Reperfusion Injury by Increasing Nitric Oxide and Hydrogen Sulfide Bioavailability.
Donnarumma E; Ali MJ; Rushing AM; Scarborough AL; Bradley JM; Organ CL; Islam KN; Polhemus DJ; Evangelista S; Cirino G; Jenkins JS; Patel RA; Lefer DJ; Goodchild TT
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381758
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotection by H2S engages a cGMP-dependent protein kinase G/phospholamban pathway.
Bibli SI; Andreadou I; Chatzianastasiou A; Tzimas C; Sanoudou D; Kranias E; Brouckaert P; Coletta C; Szabo C; Kremastinos DT; Iliodromitis EK; Papapetropoulos A
Cardiovasc Res; 2015 Jun; 106(3):432-42. PubMed ID: 25870184
[TBL] [Abstract][Full Text] [Related]
10. AP39, A Mitochondrially Targeted Hydrogen Sulfide Donor, Exerts Protective Effects in Renal Epithelial Cells Subjected to Oxidative Stress in Vitro and in Acute Renal Injury in Vivo.
Ahmad A; Olah G; Szczesny B; Wood ME; Whiteman M; Szabo C
Shock; 2016 Jan; 45(1):88-97. PubMed ID: 26513708
[TBL] [Abstract][Full Text] [Related]
11. Netrin-1 abrogates ischemia/reperfusion-induced cardiac mitochondrial dysfunction via nitric oxide-dependent attenuation of NOX4 activation and recoupling of NOS.
Siu KL; Lotz C; Ping P; Cai H
J Mol Cell Cardiol; 2015 Jan; 78():174-85. PubMed ID: 25066694
[TBL] [Abstract][Full Text] [Related]
12. GYY4137 protects against myocardial ischemia/reperfusion injury via activation of the PHLPP-1/Akt/Nrf2 signaling pathway in diabetic mice.
Qiu Y; Wu Y; Meng M; Luo M; Zhao H; Sun H; Gao S
J Surg Res; 2018 May; 225():29-39. PubMed ID: 29605032
[TBL] [Abstract][Full Text] [Related]
13. Both the H
Ahmad A; Szabo C
Pharmacol Res; 2016 Nov; 113(Pt A):348-355. PubMed ID: 27639598
[TBL] [Abstract][Full Text] [Related]
14. β3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes.
García-Prieto J; García-Ruiz JM; Sanz-Rosa D; Pun A; García-Alvarez A; Davidson SM; Fernández-Friera L; Nuno-Ayala M; Fernández-Jiménez R; Bernal JA; Izquierdo-Garcia JL; Jimenez-Borreguero J; Pizarro G; Ruiz-Cabello J; Macaya C; Fuster V; Yellon DM; Ibanez B
Basic Res Cardiol; 2014 Jul; 109(4):422. PubMed ID: 24951958
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of intermediate doses of hydrogen sulfide against myocardial ischemia-reperfusion injury in obese type 2 diabetic rats.
Jeddi S; Gheibi S; Kashfi K; Carlström M; Ghasemi A
Life Sci; 2020 Sep; 256():117855. PubMed ID: 32473245
[TBL] [Abstract][Full Text] [Related]
16. The Role of Hydrogen Sulfide and H2S-donors in Myocardial Protection Against Ischemia/Reperfusion Injury.
Citi V; Piragine E; Testai L; Breschi MC; Calderone V; Martelli A
Curr Med Chem; 2018; 25(34):4380-4401. PubMed ID: 29436990
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of Hydrogen Sulfide Preconditioning-Associated Protection Against Ischemia-Reperfusion Injury Differs in Diabetic Heart That Develops Myopathy.
Ansari M; Kurian GA
Cardiovasc Toxicol; 2020 Apr; 20(2):155-167. PubMed ID: 31317389
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening.
Ikeda G; Matoba T; Nakano Y; Nagaoka K; Ishikita A; Nakano K; Funamoto D; Sunagawa K; Egashira K
Sci Rep; 2016 Feb; 6():20467. PubMed ID: 26861678
[TBL] [Abstract][Full Text] [Related]
19. Role of carvacrol in cardioprotection against myocardial ischemia/reperfusion injury in rats through activation of MAPK/ERK and Akt/eNOS signaling pathways.
Chen Y; Ba L; Huang W; Liu Y; Pan H; Mingyao E; Shi P; Wang Y; Li S; Qi H; Sun H; Cao Y
Eur J Pharmacol; 2017 Feb; 796():90-100. PubMed ID: 27916558
[TBL] [Abstract][Full Text] [Related]
20. Hydrogen sulfide improves survival after cardiac arrest and cardiopulmonary resuscitation via a nitric oxide synthase 3-dependent mechanism in mice.
Minamishima S; Bougaki M; Sips PY; Yu JD; Minamishima YA; Elrod JW; Lefer DJ; Bloch KD; Ichinose F
Circulation; 2009 Sep; 120(10):888-96. PubMed ID: 19704099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
